Everolimus and Capecitabine in Patients With Advanced Malignancy

NCT01079702 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Advanced Malignancies

Interventions

DRUG: Everolimus
DRUG: Capecitabine

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)